01—Abstract
Summary
Summary of the 8-K filed May 8, 2025. Cited figures are marked; the original filing is the authoritative source.
Rocket Lab USA (RKLB) reported first-quarter 2025 revenue of $122.6 milliona, up 32% year over year from $92.8 million and at the top end of its guidance.
Product revenue rose to $80.8 millionb from $54.1 million, while service revenue grew more modestly to $41.8 million from $38.6 million. Profitability weakened: GAAP gross margin was about 28.8% (up from 26.1%), but operating expenses rose 40% to $94.4 million, driven by research and development (up 43%) and selling, general and administrative costs (up 37%). The operating loss widened to $59.2 million, and the net loss was $60.6 million, or $0.12 per share, versus $44.3 million a year earlier.
Adjusted EBITDA was a loss of $30.0 millionc. Operating cash flow was negative $54.2 million and capital expenditures were $28.7 million, implying free cash flow of roughly negative $83 million. The company raised about $92.8 million in gross proceeds through an at-the-market equity program and a $25 million secured term loan.
Cash, cash equivalents and marketable securities totaled roughly $512 milliond at quarter-end, based on the balance sheet. For Q2 2025, management guided to revenue of $130 million to $140 million, GAAP gross margin of 30% to 32%, and an adjusted EBITDA loss of $28 million to $30 million. Stock-based compensation is expected at $13 million to $14 million.
The guidance implies continued revenue growth alongside sustained operating losses. Strategically, the company announced a holding company reorganization, expected to be effective by June 1, 2025, in which Rocket Lab Corporation would become the new public parent. Shares would convert one-for-one, the stock would keep trading as RKLB on Nasdaq, and the reorganization is intended to be tax-free to shareholders and does not require a stockholder vote.
The company also disclosed its pending acquisition of Mynaric, which would extend its presence into Europe, and its Neutron rocket's on-ramp to the Space Force's NSSL Phase 3 Lane 1 program. For investors, the central tension is strong top-line growth and expanding government and defense demand against rising operating losses, heavy investment in Neutron and new business lines, and continued reliance on capital markets to fund the cash burn. Execution on Neutron, margin improvement, and the Mynaric integration will be key items to monitor.
02—Key points
Key Highlights
- Q1 2025 revenue of $122.6 million grew 32% year over year, at the top end of guidance, with product revenue up 49% to $80.8 million.
- GAAP operating loss widened to $59.2 million from $43.1 million as operating expenses grew 40%, with R&D up 43% to $55.1 million.
- Net loss of $60.6 million ($0.12 per share) compared with $44.3 million a year earlier; adjusted EBITDA loss was $30.0 million.
- Operating cash outflow was $54.2 million and capex was $28.7 million; the company raised about $92.8 million gross through its at-the-market equity program and $25 million through a secured term loan.
- Q2 2025 guidance calls for revenue of $130 million to $140 million, GAAP gross margin of 30% to 32%, and an adjusted EBITDA loss of $28 million to $30 million.
- Announced a holding company reorganization, expected by June 1, 2025, under which Rocket Lab Corporation becomes the public parent with a one-for-one share conversion and the RKLB ticker retained; management says it is designed to be tax-free for shareholders.
- Announced an intention to acquire Mynaric, a laser optical communications terminal provider, marking expansion into Europe; Neutron was on-ramped to the NSSL Phase 3 Lane 1 program.
03—Questions
Frequently Asked Questions
Did Rocket Lab's revenue growth translate into better profitability in Q1 2025?
Only partly. Gross profit rose to $35.2 million from $24.2 million, and GAAP gross margin improved to about 28.8% from 26.1%. However, operating expenses grew faster than revenue, so the operating loss widened to $59.2 million from $43.1 million. Non-GAAP gross margin was 33.4%, up from 31.7%.
How is Rocket Lab funding its cash burn?
Primarily through capital markets. Operating cash flow was negative $54.2 million and capex was $28.7 million. The company raised about $92.8 million gross from its at-the-market equity program and drew $25 million from a secured term loan. Cash, cash equivalents and marketable securities were roughly $512 million at March 31, 2025. Investors should watch for further dilution and debt use if burn persists.
What does the holding company reorganization mean for shareholders?
Under Section 251(g) of Delaware law, existing shares automatically convert one-for-one into Rocket Lab Corporation shares without a shareholder vote. The company says the transaction is tax-free to shareholders, and the stock is expected to keep trading as RKLB on Nasdaq under a new CUSIP. The filing states the reorganization may be delayed or not completed, and the annual meeting timing will be updated after completion.
What are the key drivers and risks behind the Q2 2025 guidance?
Guidance calls for revenue of $130 million to $140 million, GAAP gross margin of 30% to 32%, and an adjusted EBITDA loss of $28 million to $30 million. The outlook implies continued losses and depends on Electron launch cadence, government contract execution, and Neutron development progress. Management also cited the geopolitical environment as a factor in its business resilience narrative.
Why is Rocket Lab pursuing the Mynaric acquisition and NSSL eligibility?
The Mynaric acquisition, if completed, would expand Rocket Lab into Europe and add scalable production of optical communication terminals for its own satellite constellation and for government and commercial customers. The NSSL Phase 3 Lane 1 on-ramp makes Neutron eligible for national security launch missions, which could support future revenue, though Neutron's timeline and execution remain uncertain.
04—Continue